Condition
Age-Related Osteoporosis
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05151484Phase 4RecruitingPrimary
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
NCT05946278RecruitingPrimary
Genetic Regulators of Bone Health That Are Unique to Vertebral Bone
NCT05164679Not ApplicableCompletedPrimary
Training in a Local Community Aimed Upon Musculoskeletal Health Promotion for Postmenopausal Women
NCT01900860Not ApplicableCompletedPrimary
Dose-dependent Effects of Vitamin D on Bone Health
Showing all 4 trials